KU Leuven's Biosensors group develops first label-free assay characterizing COVID-19 antibodies directly in patient blood, using FOx BIOSYSTEMS platform

KU Leuven’s Biosensors group develops first label-free assay characterizing COVID-19 antibodies directly in patient blood, using FOx BIOSYSTEMS platformThe White FOx FO-SPR instrument can rapidly analyze antibody kinetic profiles against SARS-CoV-2 spike proteins in serum and whole blood from COVID-19 patients...

Related Keywords

Leuven ,Region Flamande ,Belgium ,Diepenbeek ,Kortrijk ,Belgian ,Filip Delport ,Agoralaan Abis ,Dragana Spasic ,Ku Leuven Biosensors ,Jeroen Lammertyn ,Thomas Van Elzakker ,White Fox ,University Hospital Leuven ,Sensors Division Of The Biosystems Department ,Research Manager ,Whole Blood ,Professor Jeroen Lammertyn ,Biosystems Department ,Affinity Maturation ,Plasma Iga Associate ,Clinical Outcome ,Humoral Response ,Its Relationship ,Disease Severity ,